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Summary
Background: Asthma is a heterogeneous disease of the airways that involves several
types of granulocytic inflammation. Recently, we have shown that the activation sta-
tus of myeloid cells regulated by TNFAIP3/A20 is a crucial determinant of eosinophi-
lic or neutrophilic airway inflammation. However, whether neutrophilic inflammation
observed in this model is dependent on IL‐17 remains unknown.
Objective: In this study, we investigated whether IL‐17RA‐signalling is essential for
eosinophilic or neutrophilic inflammation in house dust mite (HDM)‐driven airway
inflammation.
Methods: Tnfaip3fl/flxLyz2+/cre (Tnfaip3LysM-KO) mice were crossed to Il17raKO mice,
generating Tnfaip3LysMIl17raKO mice and subjected to an HDM‐driven airway inflam-
mation model.
Results: Both eosinophilic and neutrophilic inflammation observed in HDM‐exposed
WT and Tnfaip3LysM-KO mice respectively were unaltered in the absence of IL‐17RA.
Production of IL‐5, IL‐13 and IFN‐γ by CD4+ T cells was similar between WT, Tnfai-
p3LysM-KO and Il17raKO mice, whereas mucus‐producing cells in Tnfaip3LysM-KOIl17raKO
mice were reduced compared to controls. Strikingly, spontaneous accumulation of pul-
monary Th1, Th17 and γδ‐17 T cells was observed in Tnfaip3LysM-KOIl17raKO mice, but
not in the other genotypes. Th17 cell‐associated cytokines such as GM‐CSF and IL‐22
were increased in the lungs of HDM‐exposed Tnfaip3LysM-KOIl17raKO mice, compared
to IL‐17RA‐sufficient controls. Moreover, neutrophilic chemo‐attractants CXCL1,
CXCL2, CXCL12 and Th17‐promoting cytokines IL‐1β and IL‐6 were unaltered
between Tnfaip3LysM-KO and Tnfaip3LysM-KOIl17raKO mice.
Conclusion and Clinical Relevance: These findings show that neutrophilic airway
inflammation induced by activated TNFAIP3/A20‐deficient myeloid cells can develop
in the absence of IL‐17RA‐signalling. Neutrophilic inflammation is likely maintained
by similar quantities of pro‐inflammatory cytokines IL‐1β and IL‐6 that can, indepen-
dently of IL‐17‐signalling, induce the expression of neutrophil chemo‐attractants.
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1 | INTRODUCTION
Asthma is characterized by reversible airway obstruction, airway
remodelling and mucus production, together with increased pul-
monary inflammation.1 Granulocytic cells observed in pulmonary
inflammation of asthmatic patients can comprise eosinophils, neu-
trophils or a mixture of both cell types.2 Eosinophilic inflammation
is induced by interleukin (IL)‐5, a type 2 cytokine produced by
both Th2 cells and innate lymphoid cells type 2 (ILC2s).3 Neu-
trophilic inflammation is triggered by IL‐8 produced by airway
epithelial cells after activation by IL‐17.4 IL‐17 furthermore con-
tributes to asthma symptoms, because (a) it induces airway remod-
elling by promoting fibroblast proliferation, (b) reduces apoptosis
of smooth muscle cells and (c) increases the expression of mucin
genes in airway epithelial cells.5-7 Th17 cells primarily produce IL‐
17 and Th17‐associated neutrophilic inflammation is particularly
found in late‐onset asthma patients with a severe phenotype.8,9
Unfortunately, severe asthma patients are often unresponsive to
corticosteroid treatment, leading to frequent asthma exacerbations
and higher morbidity.2 Neutrophils and Th17 cells are likely con-
tributing to this phenotype, as both cell types are corticosteroid
insensitive.10-12 Therefore, it is imperative to investigate the con-
tribution of IL‐17‐signalling to the development of neutrophilic
asthma.
Dendritic cell (DC) activation is essential for Th cell differentia-
tion as antigen load, expression of costimulatory molecules, and
DC‐derived cytokines determine whether Th2 or Th17 cell differenti-
ation is induced.13 DC activation is controlled by TNFAIP3 (TNFα‐
induced protein 3, also known as A20), an ubiquitin modifying
enzyme that deubiquitinates several key intermediate NF‐κB sig-
nalling molecules, and thereby controls NF‐κB‐mediated cell activa-
tion.14 TNFAIP3 is also implicated in Th2‐associated disorders, as
genetic polymorphisms in TNFAIP3 and TNFAIP3 interacting protein
(TNIP) have been associated with risk of developing allergies and
asthma.15,16 Recently, we found that increasing the activation status
of DCs by ablation of the Tnfaip3 gene in myeloid cells induced a
neutrophilic inflammation in house dust mite (HDM)‐mediated
asthma protocols, which was accompanied with enhanced number of
IL‐17‐producing CD4+ T cells.17
To investigate whether the HDM‐driven neutrophilic airway
inflammation is dependent on IL‐17, we crossed myeloid‐specific
Tnfaip3 knockout mice (Tnfaip3LysM-KO mice)18 to Il17raKO mice,
generating Tnfaip3LysMIl17raKO mice, in which IL‐17A, IL‐17E and IL‐
17F‐signalling are disabled.19 Absence of IL‐17RA‐signalling in Tnfai-
p3LysM-KO mice does not significantly affect neutrophilic inflamma-
tion, most likely due to enhanced amounts of IL‐1β and IL‐6 that can
also promote the production of several neutrophil chemo‐attractants.
2 | MATERIALS AND METHODS
2.1 | Mice
Male and female C57BL/6 mice harbouring a conditional Tnfaip3 al-
lele between LoxP‐flanked sites20 were crossed to transgenic mice
expressing the Cre recombinase under the LysM promotor,21 gener-
ating Tnfaip3fl/flxLyz2+/cre mice, in which Tnfaip3 will be deleted in
cells that express or have expressed LysM18 (Tnfaip3LysM-KO mice).
Tnfaip3fl/flLyz2+/+ littermates (wild‐type (WT) mice) were used as
controls. Tnfaip3LysM mice were crossed with conventional Il17raKO
mice,22 creating Tnfaip3fl/flxLyz2+/crexIl17ra−/− mice (Tnfaip3LysM-
KOIl17raKO mice) and Tnfaip3fl/flxLyz2+/+xIl17ra−/− mice (Il17raKO
mice). Mice were housed under specific pathogen‐free conditions
and were analysed at ~8 weeks (naïve and House Dust Mite
(HDM) experiments) or at ~18 weeks (arthritis experiments). All
experiments were approved by the animal ethical committee of the
Erasmus MC, Rotterdam, the Netherlands (EMC3328 and
EMC3333).
2.2 | HDM‐induced allergic airway inflammation
During intranasal (i.n.) exposures, mice were anesthetized using
isoflurane. On day 0, mice were sensitized with 1 μg/40 μL HDM
(Greer Laboratories Inc, Lenoir, NC, USA) i.n. or with 40 μL PBS
(GIBCO Life Technologies, Carlsbad, CA, USA) as a control and chal-
lenged with 10 μg/40 μL HDM on days 7‐11. Four days after the last
challenge, bronchoalveolar lavage (BAL), lung and mediastinal lymph
node (MLN) were collected.
2.3 | Cell suspension preparation
Bronchoalveolar lavage was obtained by flushing the lungs three
times with 1 mL PBS containing 0.5 mmol/L EDTA (Sigma‐Aldrich,
St. Louis, MO, USA). The right lung was inflated with either 1:1
PBS/Tissue‐TEK O.C.T. (VWR International, Darmstadt, Germany)
solution, or snap‐frozen in liquid nitrogen, and kept at −80°C until
further processing for histology. The left lung was used for flow
cytometry. Single‐cell suspensions of the left lung were obtained
by digesting using DNase (Sigma‐Aldrich) and Liberase (Roche,
Basel, Switzerland) for 30 minutes at 37°C. After digestion, the
lungs were homogenized using a 100‐μm cell strainer (Fischer Sci-
entific, Waltham, MA, USA) and red blood cells were lysed using
osmotic lysis buffer (8.3% NH4CL, 1% KHCO3, and 0.04%
NA2EDTA in Milli‐Q). MLN and spleen were isolated for flow
cytometry, for which they were homogenized through a 100‐μm
cell strainer.
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2.4 | Flow cytometry procedures
Flow cytometry surface and intracellular staining procedures have
been described previously.23 Monoclonal antibodies used for flow
cytometric analyses are listed in Table S1. For all experiments, dead
cells were excluded using fixable viability dye (eBioscience, San Diego,
CA, USA). For measuring cytokine production, cells were stimulated
with 10 ng/mL PMA (Sigma‐Aldrich), 250 ng/mL ionomycin (Sigma‐
Aldrich) and GolgiStop (BD Biosciences, San Jose, CA, USA) for
4 hours at 37°C. Data were acquired using a LSR II flow cytometer
(BD Biosciences) with FACS DivaTM software and analysed with
FlowJo version 9 (Tree Star Inc software, Ashland, OR, USA).
2.5 | Lung histology
Six‐μm‐thick paraffin‐embedded lung sections were stained with
periodic acid‐Schiff (PAS) to visualize goblet cell hyperplasia.
2.6 | Cytokine mRNA assessment by quantitative
real‐time PCR
Homogenized left lower lung lobe was used to isolate and purify total
RNA using the GeneElute mammalian total RNA miniprep system
(Sigma‐Aldrich) and RNA quantity was determined using a NanoDrop
1000 (VWR International). Up to 0.5 μg of total RNA was reverse‐
transcribed with SuperScript II reverse transcriptase (Invitrogen, Wal-
tham, MA, USA). Gene expression was analysed for Gapdh, Cxcl1,
Cxcl2, Cxcl12, Il1b, Il6, Il22, Il23, Csf2 and Muc5a in SYBR Green Mas-
ter Mixes (Qiagen, Hilden, Germany) using an ABI Prism 7300
Sequence Detector and ABI Prism Sequence Detection Software ver-
sion 1.4 (Applied Biosystems, Foster City, CA, USA). Forward and
reverse primers for each gene are listed in Table S2. Samples were
analysed simultaneously for Gapdh mRNA as internal control. Each
sample was assayed in duplicate and relative expression was calcu-
lated as 2-ΔCt, where ΔCt is the difference between Ct of the gene of
interest and GAPDH.
2.7 | Statistical analysis
All data were presented as means ± SEM. Mann‐Whitney U tests
were used for comparison between two groups, and a P‐value of <
0.05 was considered statistically significant. All analyses were per-
formed using Prism (Version 5, GraphPad Software, La Jolla, CA, USA).
3 | RESULTS
3.1 | Loss of IL‐17RA‐signalling combined with
myeloid TNFAIP3 deficiency increases splenic
monocytes, neutrophils and γδ T cells with
progressing age
To investigate the role of IL‐17RA‐signalling in HDM‐driven neu-
trophilic airway inflammation responses, we crossed Tnfaip3LysM
mice17,18 with conventional Il17raKO mice.22 It has been demon-
strated that aged Tnfaip3LysM-KO mice develop arthritis18 and that
Il17raKO mice have altered monocyte24 and neutrophil25,26 home-
ostasis. We therefore first examined whether abrogation of IL‐17RA‐
signalling in Tnfaip3LysM-KO mice induces additional alterations in the
immune system. We assessed spleens of 8‐ and 18‐week‐old mice,
as a representation of the systemic immune state. Both 8‐ and 18‐
week‐old Tnfaip3LysM-KO and Tnfaip3LysM-KOIl17raKO mice showed
splenomegaly in comparison with WT and Il17raKO control mice (Fig-
ure 1A), whereas total splenic cell counts were only increased in 8‐
and 18‐week‐old Tnfaip3LysM-KOIl17raKO mice (Figure 1B). Mono-
cytes and neutrophils (gated as shown in Figure S1) were signifi-
cantly increased in 8‐week‐old Tnfaip3LysM-KO mice in comparison
with WT mice (Figure 1C,D), however only neutrophils were signifi-
cantly increased in 18‐week‐old Tnfaip3LysM-KO mice compared to
WT mice (Figure 1D), confirming previous findings.18 Interestingly,
both neutrophils and monocytes were significantly increased in 18‐
week‐old Tnfaip3LysM-KOIl17raKO mice compared to Tnfaip3LysM-KO
mice (Figure 1C,D). Despite elevated monocyte and neutrophil num-
bers in Tnfaip3LysM-KOIl17raKO mice, the macroscopic and micro-
scopic arthritis phenotype was similar between Tnfaip3LysM-KO mice
and Tnfaip3LysM-KOIl17raKO mice (Figure S2).
As IL‐17 controls its own expression in CD4+ T cells,25 we
assessed conventional TCRαβ T cells and γδ T cells in the spleen
(gating shown in Figure 1E). Total CD4+ T helper (Th) cell numbers
were not different between the genotypes in 8‐week‐old mice, but
were significantly increased in 18‐week‐old Il17raKO mice compared
to WT mice (Figure 1F). Splenic RORγt+ Th17 cells were elevated in
8‐week‐old Tnfaip3LysM-KOIl17raKO mice compared to Tnfaip3LysM-KO
mice, but this was no longer seen in 18‐week‐old mice (Figure 1G).
Only 18‐week‐old Il17raKO mice and Tnfaip3LysM-KOIl17raKO mice
had increased splenic γδ T cell numbers compared to respective
Il17raWT controls (Figure 1H). Splenic CD8+ T cells were reduced in
Tnfaip3LysM-KO mice and Tnfaip3LysM-KOIl17raKO mice compared to
respective Tnfaip3LysM-WT littermate controls at both ages (Figure 1I).
Splenic B cell numbers did not differ between genotypes in both 8‐
week‐old and 18‐week‐old mice (Figure 1J).Taken together, these
data show that myeloid TNFAIP3 deficiency with additional loss of
IL‐17RA‐signalling induces minimal systemic immune changes at a
young age, as only splenic Th17 cells are increased and CD8+ T cells
are decreased. In contrast, with progressing age myeloid TNFAIP3
deficient mice with abrogated IL‐17RA‐signalling accumulate splenic
monocytes, neutrophils and γδ T cells.
3.2 | House dust mite‐induced eosinophilic and
neutrophilic airway inflammation is unaltered in the
absence of IL‐17RA‐signalling
To investigate the requirement of IL‐17RA‐signalling on neutrophilic
airway inflammation, we exposed young Tnfaip3LysMIl17ra mice to an
HDM‐driven airway inflammation model (Figure 2A). As previously
shown,17 HDM‐sensitization and challenge induced a predominant
eosinophilic inflammation in WT mice compared to PBS‐sensitization,
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whereas Tnfaip3LysM-KO mice developed a primarily neutrophilic
inflammation in the bronchoalveolar lavage (BAL) (Figure 2B).
Absence of IL‐17RA‐signalling did not significantly alter eosinophilic
or neutrophilic inflammation in HDM‐sensitized Tnfaip3LysM-KOIl17-
ra
KO
mice compared to HDM‐sensitized Tnfaip3LysM-KO mice (Fig-
ure 2B). BAL DCs were increased in both HDM‐sensitized WT mice
and Il17raKO mice compared to their respective PBS‐sensitized litter-
mates (Figure 2B). However, in HDM‐sensitized Tnfaip3LysM-KO mice,
DC numbers were reduced compared to HDM‐sensitized WT mice
and were increased in HDM‐sensitized Tnfaip3LysM-KOIl17raKO
mice compared to HDM‐sensitized Tnfaip3LysM-KO mice (Figure 2B).
The absence of IL‐17RA did not significantly alter the number of
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F IGURE 1 Loss of IL‐17RA‐signalling combined with myeloid TNFAIP3 deficiency increases splenic monocytes, neutrophils and γδ T cells
with progressing age. Tnfaip3LysMIl17ra mice were analysed at 8 and 18 wk of age. A‐B, Quantification of spleen weight (A) and total cell
numbers (B). C‐D, Enumeration of monocytes (C) and neutrophils (C) analysed in spleen cell suspensions by flow cytometry. E, Flow cytometric
gating strategy of T cells and γδ T cells. Example is shown from a spleen obtained from a WT mouse. F‐H, Cell numbers are depicted of Th
cells (F), Th17 cells (G), γδ T cells (H), CD8+ T cells (I) and B cells (J) in spleen cell suspensions by flow cytometry. Results are presented as
mean ± SEM of n = 4‐10 per group and are pooled from several experiments. *P < 0.05, **P < 0.01, ***P < 0.001
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BAL macrophages in comparison with IL‐17RA sufficient controls
(Figure 2B).
HDM‐sensitized WT and Il17raKO mice exhibited enhanced small
airway mucus‐producing goblet cells and inflammatory cells compared
to their PBS‐sensitized controls (Figure 2C). HDM‐sensitized Tnfai-
p3LysM-KO mice had similar numbers of mucus‐positive cells in both
small and large airways compared to HDM‐sensitized WT mice (Fig-
ure 2C). Remarkably, with additional loss of IL‐17RA‐signalling, the
amount of goblet cells in small and large airways and lungMuc5a mRNA
levels were severely reduced in HDM‐sensitized Tnfaip3LysM-KOIl17raKO
mice compared to HDM‐sensitized Il17raKO mice (Figure 2C,D).
In HDM‐sensitized WT mice, the numbers of total T cells and
CD4+ T cells in BAL fluid increased compared to PBS‐sensitized WT
mice (Figure 2E). Total BAL T cells, Th cells and γδ T cells were
prominently elevated in HDM‐sensitized Tnfaip3LysM-KOIl17raKO mice
compared to HDM‐sensitized Tnfaip3LysM-KO mice (Figure 2E). HDM‐
sensitized Il17raKO mice had a slight increase in γδ T cells compared
to HDM‐sensitized WT mice (Figure 2E). Differences in total T cells
and γδ T cells were not observed in the MLN (Figure S3).
In conclusion, absence of IL‐17RA‐signalling did not significantly
alter eosinophilic or neutrophilic airway inflammation in respectively
HDM‐treated Il17raKO and Tnfaip3LysM-KOIl17raKO mice. In contrast,
abrogated IL‐17RA‐signalling in combination with Tnfaip3‐deficient
myeloid cells hampered goblet cell hyperplasia. While Th cells and γδ
T cells increase equally in Tnfaip3LysM-KO and WT mice upon HDM
sensitization, these populations remarkably increase with loss of IL‐
17RA‐signalling.
3.3 | Loss of IL‐17RA‐signalling does not reduce
lung Th2 cytokines in an HDM‐sensitized model, but
increases IL‐17 production
The effects of IL‐17 on Th2 differentiation in allergic asthma models
depend on the allergen used and the timing of IL‐17 exposure.27-29 As
eosinophilia and neutrophilia were only moderately affected by the
loss of IL‐17RA in HDM‐sensitized Tnfaip3LysM-WT and Tnfaip3LysM-KO
mice, we determined the effects of IL‐17RA‐signalling on cytokine
secretion by T cells upon HDM‐provoked airway inflammation. As
expected, IL‐13 and IL‐5‐expressing Th cells were increased within the
BAL of HDM‐sensitized WT mice compared to PBS‐sensitized WT
mice (Figure 3A,B). IL‐13+ and IL‐5+ Th cells were unaltered in HDM‐
sensitized Il17raKO and Tnfaip3LysM-KOIl17raKO mice compared to their
respective controls with functional IL‐17RA‐signalling (Figure 3B).
HDM‐sensitized Tnfaip3LysM-KOIl17raKO mice had reduced IL‐13+ and
IL‐5+ Th cells compared to HDM‐sensitized Il17raKO mice (Figure 3B).
As previously shown,17 BAL IL‐17+ Th cells increased in HDM‐sensi-
tized Tnfaip3LysM-KO mice compared to HDM‐sensitized WT controls.
Already in PBS‐sensitized Il17raKO mice, an increase in BAL IL‐17+ Th
cells was observed compared to PBS‐sensitized WT mice, which was
even more enhanced in HDM‐sensitized Tnfaip3LysM-KOIl17raKO mice
(Figure 3B). BAL IFN‐γ‐producing Th cells were only increased in
HDM‐sensitized Tnfaip3LysM-KOIl17raKO mice compared to either
HDM‐sensitized Il17raKO or Tnfaip3LysM-KO mice (Figure 3B).
In conclusion, lack of IL‐17RA‐signalling did not alter Th2 cytoki-
nes in HDM‐sensitized mice, which correlated with the previously
seen eosinophilic infiltrate. In contrast, IL‐17‐production and IFN‐γ‐
production by Th cells significantly increased in HDM‐sensitized
mice lacking myeloid TNFAIP3 with absent IL‐17RA‐signalling.
3.4 | Myeloid TNFAIP3‐deficient mice have IL‐
17RA‐independent increases in neutrophil
chemokines upon HDM‐sensitization
IL‐17 may contribute to neutrophil chemokine (C‐X‐C motif)
ligand (CXCL)1,30,31 CXCL222,32 and CXCL12 release.33 Since neu-
trophilic inflammation persisted in lungs of HDM‐sensitized Tnfai-
p3LysM-KOIl17raKO mice, we assessed mRNA expression levels of
these chemokines. HDM‐sensitized lungs of Tnfaip3LysM-KO mice
expressed increased amounts of Cxcl1, Cxcl2 and Cxcl12 mRNA
compared to HDM‐sensitized WT mice (Figure 4A). Surprisingly,
Cxcl1 and Cxcl12 mRNA expression did not differ between
HDM‐sensitized lungs of Tnfaip3LysM-KOIl17raKO mice and
Tnfaip3LysM-KO mice (Figure 4A). In contrast, lung Cxcl2 mRNA
expression was partially reduced in HDM‐sensitized Tnfaip3LysM-
KOIl17raKO mice as compared to HDM‐sensitized Tnfaip3LysM-KO
mice (Figure 4A). As absence of IL‐17RA‐signalling only moder-
ately influenced chemokine expression, we evaluated other pro‐
inflammatory cytokines that can promote their expression, such
as IL‐1β,30,34 IL‐635 and IL‐23.36 HDM‐treated Tnfaip3LysM-KO
mice demonstrated elevated Il1b and Il6 expression as compared
to HDM‐treated WT controls (Figure 4B). Abrogated IL‐17RA‐sig-
nalling in HDM‐exposed Tnfaip3LysM-KOIl17raKO mice resulted in
similar Il1b and Il6 cytokine expression as Tnfaip3LysM-KO mice
(Figure 4B). In contrast, Il23 expression was markedly increased
in HDM‐exposed Tnfaip3LysM-KOIl17raKO mice compared to Tnfai-
p3LysM-KO controls (Figure 4B).
Next to IL‐17A, Th17 cells can produce other cytokines, such as
granulocyte‐macrophage colony‐stimulating factor (GM‐CSF)37 and
IL‐22,38,39 which are known to regulate neutrophil chemokines
CXCL1/CXCL2 and directly attract neutrophils respectively. mRNA
expression of Csf2 and Il22 was augmented in HDM‐sensitized
Il17raKO mice compared to PBS‐sensitized Il17raKO mice (Figure 4C).
Only Il22 gene expression was further increased in HDM‐sensitized
Tnfaip3LysM-KOIl17raKO mice lungs compared to HDM‐sensitized
Il17raKO mice (Figure 4C). Both lung Csf2 and Il22 mRNA expression
were enhanced in HDM‐sensitized Tnfaip3LysM-KOIl17raKO mice com-
pared to HDM‐exposed Tnfaip3LysM-KO mice (Figure 4C), which cor-
responded to the number of Th17 cells (Figure 3B).
In summary, myeloid TNFAIP3‐deficient HDM‐sensitized mice
had elevated lung mRNA expression of the neutrophil chemokines
Cxcl1, Cxcl2 and Cxcl12, despite abrogated IL‐17RA‐signalling. IL‐
17RA‐signalling partially contributes to Cxcl2 expression in response
to HDM‐sensitization in myeloid TNFAIP3‐deficient mice. Neutrophil
chemo‐attractants are probably maintained in the absence of IL‐
17RA‐signalling by equal quantities of IL‐1β and IL‐6, that are most
likely derived from activated myeloid cells.
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4 | DISCUSSION
IL‐17 is implicated in severe and uncontrolled asthma, as patients
who suffer from severe asthma display increased levels of IL‐17 in
lung tissue.40 Recently we have shown that the presence of
intrinsically activated myeloid cells, obtained through TNFAIP3/A20
ablation, induces development of neutrophilic inflammation accom-
panied by increased Th17 cells in contrast to Th2 cell‐driven eosino-
philic inflammation induced in control mice.17 To investigate
whether neutrophilic inflammation development as observed in
F IGURE 2 House dust mite‐induced eosinophilic and neutrophilic airway inflammation is unaltered in the absence of IL‐17RA‐signalling. A,
Mice were sensitized with PBS or HDM (1 μg) on day 0 and challenged with 10 μg HDM from day 7‐11. Analysis was performed at day 15. B,
Quantification of bronchoalveolar lavage (BAL) fluid eosinophils, neutrophils, dendritic cells and macrophages by flow cytometry. C, Periodic
acid‐Schiff (PAS) stained lung small airway and large airway histology of Tnfaip3LysMIl17ra mice after HDM exposure. Scale bar indicates
200 μmol/L. D, Muc5a mRNA levels within lung homogenates of PBS‐ and HDM‐challenged Tnfaip3LysMIl17ra mice. E, Enumeration of total
CD3+ T cells, CD4+ Th cells, CD8+ T cells and γδ T cells in BAL by flow cytometry. Results are presented as mean ± SEM of n = 6 per group
and are representative of two independent experiments. *P < 0.05, **P < 0.01
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HDM‐treated Tnfaip3LysM mice is dependent on IL‐17‐signalling,
Tnfaip3LysM mice were crossed to IL‐17RA‐deficient mice.
Surprisingly, absence of IL‐17RA‐signalling had only limited
effects on neutrophilic inflammation, and neutrophil chemo‐attrac-
tants in our HDM‐driven airway inflammation mouse model. Ablation
of IL‐17RA‐signalling increased the number of Th1 and Th17 cells,
whereas Th2 cell differentiation and eosinophilic inflammation were
not hampered. Strikingly, the presence of mucus‐producing cells was
severely reduced in mice with deficient IL‐17RA‐signalling and
TNFAIP3‐deficient myeloid cells.
The IL‐17RA subunit forms a heterodimer with either the IL‐
17RC or IL‐17RB subunit. IL‐17RA/C heterodimer is used by IL‐17A,
IL‐17F and IL‐17A/F and the IL‐17RA/B heterodimer is activated by
IL‐17E (also known as IL‐25).19 Ablation of the IL‐17RA subunit will
therefore affect the signalling of IL‐17A, IL‐17F, IL‐17A/F and IL‐25.
We observed that neutrophilic inflammation and neutrophil chemo‐
attractants persisted in the absence of IL‐17RA‐signalling, indicating
that neutrophilia can develop without the presence of the described
IL‐17R family members IL‐17A, IL‐17F and IL‐25. This is in contrast
to other reports that showed dependency of neutrophil influx on IL‐
17RA‐signalling not only in asthma and COPD, but also in pulmonary
bacterial and viral infections.9,10,22,41-43 Neutrophil chemo‐attractants
CXCL1, CXCL2 and CXCL12 were not altered upon ablation of IL‐
17RA‐signalling indicating that these chemo‐attractants can be
induced by factors independent of IL‐17RA‐signalling. Similar quanti-
ties of Th17‐promoting cytokines IL‐1β and IL‐6 were found in the
lungs of HDM‐exposed Tnfaip3LysM-KO and Tnfaip3LysM-KOIl17raKO
mice, whereas IL‐23 expression was increased in HDM‐exposed
Tnfaip3LysM-KOIl17raKO as compared to Tnfaip3LysM-KO mice. IL‐1β
has been shown to induce CXCL1 as efficiently as IL‐17 by mouse
embryonic fibroblasts.30 Furthermore, IL‐1β‐deficient mice have
defective neutrophil mobilization upon group B streptococcus infec-
tion, most likely caused by strongly reduced CXCL1 and CXCL2 pro-
duction.34 Likewise, IL‐6 can induce CXCL1 transcription in
endothelial cells.35 This could indicate that pulmonary IL‐1β and IL‐6
expression in Tnfaip3LysM-KOIl17raKO mice can induce CXCL1 expres-
sion by lung epithelial cells, independent of IL‐17RA‐signalling.
Ablation of IL‐17RA‐signalling alone only slightly increases the
presence of IL‐17‐expressing T cells, however combined with
Tnfaip3‐deficient myeloid cells, pulmonary Th17 cells were massively
enhanced in allergen‐exposed Tnfaip3LysM-KOIl17raKO mice. Increased
pulmonary IL‐23‐expression, high levels of IL‐1β and IL‐6, and defec-
tive negative feedback normally provided by IL‐17 in Tnfaip3LysM-
KOIl17raKO mice could be responsible for this massive increase. It is
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F IGURE 3 Loss of IL‐17RA‐signalling does not affect lung Th2 cytokines in a HDM‐sensitized model, but increases IL‐17 production.
Tnfaip3LysMIl17ra mice were analysed after completion of the HDM exposure protocol. A, Flow cytometry data are shown of intracellular
cytokine expression within Th cells of bronchoalveolar lavage (BAL) of representative HDM‐exposed mice. B, Quantification of BAL Th cell
cytokines IL‐13, IL‐5, IL‐17 and IFN‐γ as determined by flow cytometry. Results are presented as mean ± SEM of n = 6 per group and are
representative of two independent experiments. *P < 0.05, **P < 0.01
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known that IL‐23 expression by myeloid cells such as DCs and
macrophages drives clonal expansion of Th17 cells,44 whereas IL‐17
acts as a negative feedback to control its own expression.25 Strik-
ingly, only IL‐23, and not IL‐1β and IL‐6, was specifically increased in
Tnfaip3LysM-KOIl17raKO mice when compared to Tnfaip3LysM-KO mice,
suggesting that IL‐17RA‐signalling also controls IL‐23 production.
We found limited effects of defective IL‐17RA‐signalling on all
features observed in HDM‐mediated allergic airway inflammation
including Th2 differentiation and eosinophilic inflammation. This
implicates that IL‐17A, IL‐17A/F, IL‐17F and IL‐25 are dispensable for
Th2‐mediated eosinophilic inflammation upon HDM treatment.
Blockade of IL‐17A also did not influence eosinophilic inflammation
and Th2 cytokine secretion upon exposure to the HDM Der f aller-
gen.41 This is in contrast to ovalbumin (OVA)‐mediated allergic air-
way models, where reduced eosinophilic inflammation, Th2
cytokines and airway hyperresponsiveness (AHR) were observed in
either IL‐17RA‐deficient or IL‐17‐deficient mice.27,28 This suggests
that the importance of IL‐17 depends on the allergen/model used.
While IL‐17‐depletion during HDM challenges has no effect on eosi-
nophilia and Th2 cytokines,41 blockade of IL‐17 during challenge in
OVA‐mediated models promotes Th2‐mediated eosinophilic inflam-
mation.27 Treatment with recombinant IL‐17 promotes inflammatory
resolution upon OVA‐mediated airway inflammation,29 indicating
that IL‐17 during the resolution phase can be beneficial.
Next to airway type‐2 inflammation, goblet cell hyperplasia was
also almost completely absent in Tnfaip3LysM-KOIl17raKO mice. This
suggests that the presence of Th2 cytokines in WT mice, or Th17
cytokines in Tnfaip3LysM-KO, is essential for goblet cell hyperplasia.
Indeed, mucus production by goblet cells is induced by Th2 cytoki-
nes IL‐4, IL‐1345-48 and Th17 cytokines IL‐17A7 and IL‐17F.49 Fur-
thermore, IL‐25 (eg, IL‐17E) is also implicated in goblet cell
hyperplasia.50,51 The combination of OVA‐specific Th2 and Th17
cells was shown to induce more mucus‐producing goblet cells than
OVA‐specific Th2 cells alone.52 This indicates that both Th2 and
Th17 cytokines can induce hyperplasia of mucus‐producing cells sep-
arately and can even take over each other function, as combined
absence of Th2 cytokines and abrogated IL‐17RA‐signalling in Tnfai-
p3LysM-KOIl17raKO mice completely hampers the induction of goblet
cell hyperplasia. Furthermore, mucus production by goblet cells in
Il17raKO mice develops independent of IL‐25.
In conclusion, our results show that neutrophilic airway inflam-
mation induced by activated TNFAIP3/A20‐deficient myeloid cells
can develop in the absence of IL‐17RA‐signalling. Increased pul-
monary pro‐inflammatory cytokines IL‐1β and IL‐6 quantities are not
influenced by IL‐17RA‐deficiency in mice with activated myeloid cells
after HDM exposure. Both IL‐1b and IL‐6 can induce the expression
of neutrophil chemo‐attractants, contributing to neutrophilic airway
inflammation independently of IL‐17‐signalling.
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